Exhibit 99.3

 

  

THE JOINT CORP. AND SUBSIDIARY AND AFFILIATES

UNAUDITED PRO FORMA

CONDENSED COMBINED FINANCIAL STATEMENTS

 

 

On August 1, 2019, The Joint Corp. (the “Company”) completed its purchase of one franchisee clinic, located in Myrtle Beach, South Carolina (the “acquisition”). The acquisition was accomplished pursuant to an Asset and Franchise Purchase Agreement (the “Purchase Agreement”) among the Company, RJJ, LLC, a South Carolina limited liability company (“Seller”), and Robin Willey and Judy Willey (together, the “Shareholders”). The Company intends to own and operate the clinic. The total consideration for the acquisition was $750,000, of which $700,000 was paid in cash up front, and $50,000 is payable 90 calendar days after the closing date, each subject to certain adjustments. The Purchase Agreement was filed with the Securities and Exchange Commission (the “SEC”) as an exhibit to the Company’s Current Report on Form 8-K filed on August 5, 2019.

 

Included herein are the unaudited pro forma condensed combined financial statements, which are not necessarily indicative of what the Company’s financial position or results of operations would have been had the Company completed the acquisition at the dates indicated. In addition, the unaudited pro forma condensed combined financial information does not purport to project the future financial position or operating results of the Company after the acquisition. The pro forma information is based on the assumptions, adjustments and eliminations described in the accompanying notes to the unaudited pro forma condensed combined financial statements, which form an integral part of the statements.

 

The following unaudited pro forma condensed combined financial statements combine the historical consolidated financial statements of the Company, and the historical financial statements of RJJ, LLC adjusted to give effect to the impact of the acquisition and related financing transactions. The unaudited pro forma condensed combined balance sheet presents the combined financial position giving effect to the acquisition and related financing transactions as if they had occurred on June 30, 2019. Because the Company acquired only certain assets from RJJ, LLC, the Company have presented the acquisition of such assets in the pro forma adjustments column. The assets acquired were the assets that derived all of RJJ, LLC’s revenue, and therefore, the Company has included a sperate column for the combined statements of operations pro forma presentation. The unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2019 and for the year ended December 31, 2018 present the combined results of operations as if the acquisition had occurred on January 1, 2018. These unaudited pro forma condensed combined financial statements have been prepared in accordance with Regulation S-X Article 11.

 

These unaudited pro forma condensed combined financial statements should be read in connection with:

 

·Separate historical financial statements of the Company as of and for the year ended December 31, 2018, which are incorporated by reference to its Annual Report on Form 10-K; and
·Separate historical financial statements of the Company as of and for the six months ended June 30, 2019, which are incorporated by reference to its Quarterly Report on Form 10-Q for the six months ended June 30, 2019.

 

 

 

 1 

 

THE JOINT CORP. AND SUBSIDIARY AND AFFILIATES

UNAUDITED PRO FORMA

CONDENSED COMBINED BALANCE SHEET

 

As of June 30, 2019

 

 

   The Joint
Corp.
  Pro Forma
Adjustments
   Pro Forma
Condensed
Combined
ASSETS                 
Current assets:                 
Cash and cash equivalents  $9,485,212   $(677,414) (a)  $8,807,798 
Restricted cash   129,220    -      129,220 
Accounts receivable, net   1,033,479    -      1,033,479 
Income taxes receivable   -    -      - 
Notes receivable - current portion   163,573    -      163,573 
Deferred franchise costs - current portion   710,796    (1,530) (g)   709,266 
Prepaid expenses and other current assets   887,676    -      887,676 
Total current assets   12,409,956    (678,944)     11,731,012 
Property and equipment, net   4,963,037    28,662  (b)   4,991,699 
Operating lease right-of-use asset   10,030,737    166,892  (h)   10,197,629 
Notes receivable, net of current portion   41,683    -      41,683 
Deferred franchise costs, net of current portion   3,485,644    (4,318) (g)   3,481,326 
Intangible assets, net   1,975,835    496,930  (c)   2,472,765 
Goodwill   3,225,145    194,545  (d)   3,419,690 
Deposits and other assets   337,379    -      337,379 
Total assets  $36,469,416   $203,767     $36,673,183 
                  
LIABILITIES AND STOCKHOLDERS' EQUITY                 
Current liabilities:                 
Accounts payable  $1,199,341   $-     $1,199,341 
Accrued expenses   178,949    -      178,949 
Co-op funds liability   129,220    -      129,220 
Payroll liabilities   1,602,916    -      1,602,916 
Notes payable - current portion   1,000,000    50,000  (a)   1,050,000 
Operating lease liability - current portion   1,827,233    26,452  (h)   1,853,685 
Finance lease liability - current portion   23,075    -      23,075 
Deferred franchise revenue - current portion   2,697,669    (2,700) (f)   2,694,969 
Deferred revenue from company clinics   2,677,782    22,586   (e)    2,700,368 
Other current liabilities   540,279    -      540,279 
Total current liabilities   11,876,464    96,338      11,972,802 
Operating lease liability - net of current portion   9,049,948    115,812  (h)   9,165,760 
Finance lease liability - net of current portion   46,826    -      46,826 
Deferred franchise revenue, net of current portion   12,652,780    (8,383) (f)   12,644,397 
Deferred tax liability   83,294    -      83,294 
Other liabilities   27,230    -      27,230 
Total liabilities   33,736,542    203,767      33,940,309 
Commitments and contingencies                 
Stockholders' equity:                 
Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 issued and outstanding, as of December 31, 2018 and 2017   -    -      - 
Common stock   13,838    -      13,838 
Additional paid-in capital   38,779,538    -      38,779,538 
Treasury stock   (90,856)   -      (90,856)
Accumulated deficit   (35,969,746)   -      (35,969,746)
Total The Joint Corp. stockholders' equity   2,732,774    -      2,732,774 
Non-controlling Interest   100    -      100 
Total equity   2,732,874    -      2,732,874 
Total liabilities and stockholders' equity  $36,469,416   $203,767     $36,673,183 

 

 

The accompanying notes are an integral part of these financial statements

 

 

 2 

 

THE JOINT CORP. AND SUBSIDIARY AND AFFILIATES

UNAUDITED PRO FORMA

CONDENSED COMBINED STATEMENTS OF OPERATIONS

 

Year Ended December 31, 2018

 

 

   The Joint Corp.
(as adjusted)
  RJJ, LLC  Pro Forma
Adjustments
   Pro Forma
Adjustments
   Pro Forma
Adjustments
    Pro Forma
Condensed
Combined
Revenues:                                     
Revenues from company-owned or managed clinics  $19,545,276   $572,877   $-     $-     $-      $20,118,153 
Royalty fees   10,141,036    -    (53,179) (i)   -      -       10,087,857 
Franchise fees   1,688,039    -    15,708  (f)   (2,900) (j)   -       1,700,847 
Advertising fund revenue   2,862,244    -    -      -      -       2,862,244 
Software fees   1,290,135    -    (3,300) (k)   -      -       1,286,835 
Regional developer fees   599,370    -    -      -      -       599,370 
Other revenues   535,560    -    -      -      -       535,560 
Total revenues   36,661,660    572,877    (40,771)     (2,900)     -       37,190,866 
Cost of revenues:                                     
Franchise cost of revenues   3,956,530    -    6,758  (g)   -      -       3,963,288 
IT cost of revenues   353,719    -    -      -      -       353,719 
Total cost of revenues   4,310,249    -    6,758      -      -       4,317,007 
Selling and marketing expenses   4,819,555    19,611    -      -      -       4,839,166 
Depreciation and amortization   1,556,240    10,137    150,885  (c)   (2,900) (j)   15,708  (f)    1,730,070 
General and administrative expenses   25,238,121    448,976    -      (53,179)  (i)    (3,300) (k)    25,630,618 
Total selling, general and administrative expenses   31,613,916    478,724    150,885      (56,079)     12,408       32,199,854 
Net loss on disposition or impairment   593,960    -    -      -      -       593,960 
Income (loss) from operations   143,535    94,153    (198,414)     53,179      (12,408)      80,045 
                                      
Other income (expense):                                     
Bargain purchase gain   13,198    -    -      -      -       13,198 
Other expense, net   (47,765)   (2,248)   -      -      -       (50,013)
Total other expense   (34,567)   (2,248)   -      -      -       (36,815)
                                      
Income (loss) before income tax expense   108,968    91,905    (198,414)     53,179      (12,408)      43,230 
                                      
Income tax benefit   37,728    -    -   (l)    -      -       37,728 
                                      
Net income (loss) and comprehensive income (loss)  $146,696   $91,905   $(198,414)    $53,179     $(12,408)     $80,958 
                                      
Earnings per share:                                     
                                      
Basic earnings per share  $0.01                              $0.01 
Diluted earnings per share  $0.01                              $0.01 
                                      
Basic weighted average shares   13,669,107                               13,669,107 
Diluted weighted average shares   14,031,717                               14,031,717 

 

 

The accompanying notes are an integral part of these financial statements

 

 3 

 

THE JOINT CORP. AND SUBSIDIARY AND AFFILIATES

UNAUDITED PRO FORMA

CONDENSED COMBINED STATEMENTS OF OPERATIONS

 

Six Months Ended June 30, 2019

 

 

   The Joint
Corp.
  RJJ, LLC  Pro Forma
Adjustments
   Pro Forma
Adjustments
   Pro Forma
Condensed
Combined
Revenues:                             
Revenues from company-owned or managed clinics  $11,416,365   $355,808   $-     $-     $11,772,173 
Royalty fees   6,290,346    -    (32,188) (i)   -      6,258,158 
Franchise fees   864,339    -    (1,450) (j)   -      862,889 
Advertising fund revenue   1,819,367    -    -      -      1,819,367 
Software fees   742,361    -    (1,650) (k)   -      740,711 
Regional developer fees   384,381    -    -      -      384,381 
Other revenues   332,197    -    -      -      332,197 
Total revenues   21,849,356    355,808    (35,288)     -      22,169,876 
Cost of revenues:                             
Franchise cost of revenues   2,315,431    -    (765) (g)   -      2,314,666 
IT cost of revenues   189,659    -    -      -      189,659 
Total cost of revenues   2,505,090    -    (765)     -      2,504,325 
Selling and marketing expenses   3,275,356    14,970    -      -      3,290,326 
Depreciation and amortization   770,143    4,694    75,443  (c)   (1,450) (j)   848,830 
General and administrative expenses   13,780,566    260,761    (32,188)  (i)    (1,650) (k)   14,007,489 
Total selling, general and administrative expenses   17,826,065    280,425    43,255      (3,100)     18,146,645 
Net loss on disposition or impairment   86,927    -    -      -      86,927 
Income (loss) from operations   1,431,274    75,383    (77,778)     3,100      1,431,979 
                              
Other income (expense):                             
Bargain purchase gain   19,298    -    -      -      19,298 
Other expense, net   (26,771)   (105)   -      -      (26,876)
Total other expense   (7,473)   (105)   -      -      (7,578)
                              
Income (loss) before income tax expense   1,423,801    75,278    (77,778)     3,100      1,424,401 
                              
Income tax expense   (8,896)   -    -   (l)    -      (8,896)
                              
Net income (loss) and comprehensive income (loss)  $1,414,905   $75,278   $(77,778)    $3,100     $1,415,505 
                              
Earnings per share:                             
                              
Basic earnings per share  $0.10                      $0.10 
Diluted earnings per share  $0.10                      $0.10 
                              
Basic weighted average shares   13,774,474                       13,774,474 
Diluted weighted average shares   14,390,320                       14,390,320 

 

 

The accompanying notes are an integral part of these financial statements

 

 4 

 

THE JOINT CORP. AND SUBSIDIARY AND AFFILIATES

 

NOTES TO UNAUDITED PRO FORMA

CONDENSED COMBINED FINANCIAL STATEMENTS

 

 

Note 1: Background and Basis of Presentation

 

On August 1, 2019, the Company completed its purchase of one franchisee clinic, RJJ, LLC, for $750,000, which consisted of $700,000 paid in cash (less $22,586 of certain adjustment as defined by the Purchase Agreement) and a $50,000 note issued to the seller.

 

The historical condensed financial statements have been adjusted in the unaudited pro forma condensed combined financial information to give effect to pro forma events that are i) directly attributable to the acquisition and related financing transactions, ii) factually supportable and iii) with respect to the unaudited pro forma condensed combined statements of operations, expected to have a continuing impact on the combined results following the acquisition.

 

The unaudited pro forma condensed combined financial statements are not necessarily indicative of what the Company’s financial position or results of operations would have been had the Company completed the acquisition and related financing transactions at the dates indicated. In addition, the unaudited pro forma condensed combined financial information does not purport to project the future financial position or operating results of the Company after the acquisition. The pro forma information is based on the assumptions, adjustments and eliminations described in the accompanying notes to the unaudited pro forma condensed combined financial statements. The pro forma adjustments are preliminary and are subject to change as more information becomes available and after final analysis of fair values of tangible and intangible assets acquired and liabilities assumed are complete. A final determination of the fair value for certain assets and liabilities will be completed as soon as the information necessary to complete the analysis is obtained, but no later than one year from the acquisition date. Differences between all preliminary estimates included herein and the final acquisition accounting may occur and these differences could be material.

 

Note 2: Estimate of Assets Acquired

 

The acquisition will be accounted for using the acquisition method of accounting in accordance with Accounting Standards Codification 805 - Business Combinations (“ASC 805”), which requires, among other things, that the assets acquired and liabilities assumed be recognized at their acquisition date fair values, with any excess of the consideration transferred over the estimated fair values of the identifiable net assets acquired recorded to goodwill.

 

The total purchase price for the transaction to acquire RJJ, LLC was $727,414, less the recognition of $5,236 of net deferred revenue associated with RJJ, LLC, resulting in total purchase consideration of $722,178. Total purchase price consideration was allocated to assets as follows:

 

Property and equipment  $28,662 
Intangible assets   496,930 
Operating lease right-of-use asset   166,892 
Operating lease liability - current portion   (26,452)
Operating lease liability - net of current portion   (115,813)
Deferred revenue   (22,586)
Total net assets acquired   527,633 
Goodwill   194,545 
Net purchase price  $722,178 

 

The pro forma purchase price allocation is subject to further adjustment as additional information becomes available and analyses are completed. The final allocation of amounts to assets acquired and liabilities assumed could differ materially from the preliminary amounts presented in these unaudited pro forma condensed combined financial statements. A decrease in the fair value of assets acquired or an increase in the fair value of liabilities assumed from the preliminary valuations presented in these unaudited pro forma condensed combined financial statements would likely result in a dollar-for-dollar corresponding increase in the amount of goodwill that will result from the acquisition. In addition, if the value of the acquired assets is higher than the preliminary indication, it may result in higher amortization and depreciation expense than is presented in these unaudited pro forma condensed combined financial statements.

 

 5 

 

 

Intangible assets consist of reacquired franchise rights of $390,320 and customer relationships of $106,610 and will be amortized over their estimated useful lives of four and two years, respectively. These preliminary estimates of fair value and useful lives could be different from the final acquisition accounting, and the difference could have a material impact on the Company’s consolidated financial statements.

 

Note 3: Pro forma adjustments

 

(a)Adjustment to cash and note payable in connection with the purchase consideration paid.

 

(b)Adjustment to record property, plant and equipment at the preliminary fair market value which consisted of leasehold improvement of $28,662 to be depreciated over approximately five years.

 

(c)Adjustment to record intangible assets and the related additional amortization expense. Intangible assets consist of reacquired franchise rights of $390,320 amortized over an estimated useful life of four years and customer relationships of $106,610 amortized over an estimated useful life of two years.

 

(d)Adjustment to record goodwill as a result of the acquisition. Goodwill represents the excess of the consideration transferred over the preliminary fair value of the assets acquired and liabilities assumed as described in Note 2. The goodwill will not be amortized, but instead will be tested for impairment annually and whenever events and circumstances have occurred that may indicate a possible impairment exists. In the event management determines that the value of goodwill has become impaired, the Company will incur an accounting charge for the amount of the impairment during the period in which the determination is made.

 

(e)Adjustment to record deferred revenue related to the wellness packages sold by RJJ, LLC as a result of the acquisition.

 

(f)Adjustment to eliminate deferred franchise revenue related to RJJ, LLC.

 

(g)Adjustment to eliminate deferred franchise costs and related amortization expense associated with RJJ, LLC.

 

(h)Adjustment to record the impact of the adoption of Accounting Standards Codification 842 - Leases related to assumed leases, resulting in a preliminary estimated fair value of acquired right of use lease assets of $166,892 (including the impact of favorable lease assumed), assumed short-term lease liabilities of $26,452, and long-term lease liabilities of $115,813.

 

(i)Adjustment to eliminate royalty fees (including advertising fee) paid to the Company by RJJ, LLC that are intercompany in nature on a combined basis.

 

(j)Adjustment to eliminate franchise fees recognized by the Company that are intercompany in nature on a combined basis.

 

(k)Adjustment to eliminate software fees paid to the Company by RJJ, LLC that are intercompany in nature on a combined basis.

 

(l)No pro forma adjustment to income taxes was made to the condensed combined statements of operations, as any income tax benefit generated would be fully reserved for, resulting in a net zero impact to income taxes.

 

 

 

6